The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | M | Musculo-skeletal system | |
| 2 | M03 | Muscle relaxants | |
| 3 | M03A | Muscle relaxants, peripherally acting agents | |
| 4 | M03AC | Other quaternary ammonium compounds | |
| 5 | M03AC01 | Pancuronium |
| Active Ingredient | Description | |
|---|---|---|
| Pancuronium |
Pancuronium produces pharmacologic effects similar to those of other non-depolarising neuromuscular blocking agents. The drug may produce an increase in heart rate which appears to result from a direct blocking effect on the acetylcholine receptors of the heart. Pancuronium causes little or no histamine release and no ganglionic blockade and therefore does not cause hypotension or bronchospasm. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| PANCURONIUM BROMIDE Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
